• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病中的血浆三羧酸循环中间产物

Plasma Krebs Cycle Intermediates in Nonalcoholic Fatty Liver Disease.

作者信息

Sandlers Yana, Shah Rohan R, Pearce Ryan W, Dasarathy Jaividhya, McCullough Arthur J, Dasarathy Srinivasan

机构信息

Department of Chemistry, Cleveland State University, Cleveland, OH 44115, USA.

MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, 44139, USA.

出版信息

J Clin Med. 2020 Jan 22;9(2):314. doi: 10.3390/jcm9020314.

DOI:10.3390/jcm9020314
PMID:31979094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7073566/
Abstract

Nonalcoholic liver disease (NAFLD) is manifested with a wide spectrum of clinical symptoms and is closely associated with the metabolic syndrome, inflammation, and mitochondrial dysfunction. Although the mechanism of mitochondrial dysfunction in NAFLD is still not fully elucidated, multiple studies have demonstrated evidence of molecular, biochemical, and biophysical mitochondrial abnormalities in NAFLD. Given the association between NAFLD and mitochondrial dysfunction, the aim of this study is to analyze circulating levels of Krebs cycle intermediates in a cohort of NAFLD-affected individuals and matching healthy controls and to correlate our findings with the liver function metrics. Standard serum biochemistry and Krebs cycle intermediates were analyzed in NAFLD ( = 22) and matched control ( = 67) cohorts. Circulating levels of isocitrate and citrate were significantly ( < 0.05) elevated in the NAFLD cohort of patients. The area under the curve (AUROC) for these two metabolites exhibited a moderate clinical utility. Correlations between plasma Krebs cycle intermediates and standard clinical plasma metrics were explored by Pearson's correlation coefficient. The data obtained for plasma Krebs cycle intermediates suggest pathophysiological insights that link mitochondrial dysfunction with NAFLD. Our findings reveal that plasma isocitrate and citrate can discriminate between normal and NAFLD cohorts and can be utilized as noninvasive markers of mitochondrial dysfunction in NAFLD. Future studies with large populations at different NAFLD stages are warranted.

摘要

非酒精性肝病(NAFLD)表现出广泛的临床症状,并且与代谢综合征、炎症和线粒体功能障碍密切相关。尽管NAFLD中线粒体功能障碍的机制仍未完全阐明,但多项研究已证明NAFLD中存在分子、生化和生物物理线粒体异常的证据。鉴于NAFLD与线粒体功能障碍之间的关联,本研究的目的是分析一组受NAFLD影响的个体和匹配的健康对照者中 Krebs 循环中间体的循环水平,并将我们的发现与肝功能指标相关联。对NAFLD组(n = 22)和匹配的对照组(n = 67)进行了标准血清生化和 Krebs 循环中间体分析。NAFLD患者队列中异柠檬酸和柠檬酸的循环水平显著升高(P < 0.05)。这两种代谢物的曲线下面积(AUROC)显示出中等的临床实用性。通过Pearson相关系数探讨血浆Krebs循环中间体与标准临床血浆指标之间的相关性。血浆Krebs循环中间体获得的数据提示了将线粒体功能障碍与NAFLD联系起来的病理生理学见解。我们的研究结果表明,血浆异柠檬酸和柠檬酸可以区分正常人群和NAFLD人群,并可作为NAFLD中线粒体功能障碍的非侵入性标志物。有必要对处于不同NAFLD阶段的大量人群进行进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a61/7073566/f3e32e635631/jcm-09-00314-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a61/7073566/a9c622a54cf4/jcm-09-00314-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a61/7073566/04e2ba497f3d/jcm-09-00314-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a61/7073566/f3e32e635631/jcm-09-00314-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a61/7073566/a9c622a54cf4/jcm-09-00314-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a61/7073566/04e2ba497f3d/jcm-09-00314-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a61/7073566/f3e32e635631/jcm-09-00314-g003a.jpg

相似文献

1
Plasma Krebs Cycle Intermediates in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的血浆三羧酸循环中间产物
J Clin Med. 2020 Jan 22;9(2):314. doi: 10.3390/jcm9020314.
2
Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease.在非酒精性脂肪性肝病中,支链氨基酸与肝脏线粒体之间的相互作用受到损害。
Am J Physiol Endocrinol Metab. 2015 Aug 15;309(4):E311-9. doi: 10.1152/ajpendo.00161.2015. Epub 2015 Jun 9.
3
Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.经活检证实的非酒精性脂肪性肝病患者血清可溶性凝集素样氧化型低密度脂蛋白受体-1水平升高。
World J Gastroenterol. 2015 Jul 14;21(26):8096-102. doi: 10.3748/wjg.v21.i26.8096.
4
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.与健康正常体重个体相比,不同程度非酒精性脂肪性肝病患者的肝转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G462-G472. doi: 10.1152/ajpgi.00358.2018. Epub 2019 Jan 17.
5
Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.肝脏丙氨酸可将人类和小鼠的非酒精性脂肪性肝炎与单纯性脂肪变性区分开来:质子磁共振波谱研究与长回波时间。
J Magn Reson Imaging. 2017 Nov;46(5):1298-1310. doi: 10.1002/jmri.25673. Epub 2017 Feb 22.
6
Nonalcoholic Fatty Liver Disease is Associated with Erectile Dysfunction: A Prospective Pilot Study.非酒精性脂肪性肝病与勃起功能障碍相关:一项前瞻性试点研究。
J Sex Med. 2016 Mar;13(3):383-8. doi: 10.1016/j.jsxm.2015.12.030. Epub 2016 Feb 4.
7
Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.经活检证实的非酒精性脂肪性肝病患儿循环中连蛋白增加。
World J Gastroenterol. 2014 Dec 7;20(45):17107-14. doi: 10.3748/wjg.v20.i45.17107.
8
Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者循环血清miR-34a和miR-122与血脂异常的关联
PLoS One. 2016 Apr 14;11(4):e0153497. doi: 10.1371/journal.pone.0153497. eCollection 2016.
9
Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.血浆胎球蛋白-A 与非酒精性脂肪性肝病患者的内皮功能障碍和亚临床动脉粥样硬化有关。
Clin Endocrinol (Oxf). 2013 May;78(5):712-7. doi: 10.1111/j.1365-2265.2012.04460.x.
10
The association between the metabolic syndrome and alanine amino transferase is mediated by insulin resistance via related metabolic intermediates (the Cohort on Diabetes and Atherosclerosis Maastricht [CODAM] study).代谢综合征与丙氨酸氨基转移酶之间的关联是通过胰岛素抵抗及其相关代谢中间产物介导的(马斯特里赫特糖尿病和动脉粥样硬化队列研究[CODAM])。
Metabolism. 2011 Jul;60(7):969-75. doi: 10.1016/j.metabol.2010.09.006. Epub 2010 Oct 30.

引用本文的文献

1
Protective effects of Nogo-B deficiency in NAFLD mice and its multiomics analysis of gut microbiology and metabolism.Nogo-B缺乏对非酒精性脂肪性肝病(NAFLD)小鼠的保护作用及其肠道微生物群和代谢的多组学分析
Genes Nutr. 2024 Aug 24;19(1):17. doi: 10.1186/s12263-024-00754-5.
2
Mitochondrial citrate accumulation drives alveolar epithelial cell necroptosis in lipopolysaccharide-induced acute lung injury.线粒体柠檬酸积累驱动脂多糖诱导的急性肺损伤中肺泡上皮细胞坏死性凋亡。
Exp Mol Med. 2022 Nov;54(11):2077-2091. doi: 10.1038/s12276-022-00889-8. Epub 2022 Nov 28.
3
Growth hormone ameliorates hepatopulmonary syndrome and nonalcoholic steatohepatitis secondary to hypopituitarism in a child: A case report.

本文引用的文献

1
Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations.非酒精性脂肪性肝病和酒精性肝病:具有全身表现的代谢性疾病。
Transl Gastroenterol Hepatol. 2019 Sep 3;4:65. doi: 10.21037/tgh.2019.08.09. eCollection 2019.
2
Ammonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver Disease.氨清除防止实验性非酒精性脂肪性肝病纤维化进展。
Hepatology. 2020 Mar;71(3):874-892. doi: 10.1002/hep.30890. Epub 2019 Oct 15.
3
Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts.
生长激素改善儿童垂体功能减退继发的肝肺综合征和非酒精性脂肪性肝炎:一例报告
World J Clin Cases. 2022 Jun 26;10(18):6211-6217. doi: 10.12998/wjcc.v10.i18.6211.
4
A Pilot Study of Bioenergetic Marker Relationships in Gulf War Illness: Phosphocreatine Recovery vs. Citric Acid Cycle Intermediates.海湾战争疾病生物能量标志物关系的初步研究:磷酸肌酸恢复与柠檬酸循环中间产物。
Int J Environ Res Public Health. 2021 Feb 9;18(4):1635. doi: 10.3390/ijerph18041635.
在四个欧洲队列中对诊断为非酒精性脂肪性肝病的成年人进行的真实世界研究:肝硬化和肝细胞癌诊断的风险和临床预测因子。
BMC Med. 2019 May 20;17(1):95. doi: 10.1186/s12916-019-1321-x.
4
IDH2 protects against nonalcoholic steatohepatitis by alleviating dyslipidemia regulated by oxidative stress.异柠檬酸脱氢酶 2 通过减轻氧化应激调节的血脂异常来预防非酒精性脂肪性肝炎。
Biochem Biophys Res Commun. 2019 Jun 30;514(3):593-600. doi: 10.1016/j.bbrc.2019.04.069. Epub 2019 May 4.
5
Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study.三酰甘油与高密度脂蛋白胆固醇比值作为非酒精性脂肪性肝病的替代指标:一项横断面研究。
Lipids Health Dis. 2019 Feb 2;18(1):39. doi: 10.1186/s12944-019-0986-7.
6
Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications.非酒精性脂肪性肝病相关肝细胞癌的流行病学及其影响
JGH Open. 2018 Jul 17;2(5):235-241. doi: 10.1002/jgh3.12070. eCollection 2018 Oct.
7
Association between body mass index and fatty liver risk: A dose-response analysis.体重指数与脂肪肝风险的关联:剂量反应分析。
Sci Rep. 2018 Oct 15;8(1):15273. doi: 10.1038/s41598-018-33419-6.
8
Hepatic Mitochondrial Defects in a Nonalcoholic Fatty Liver Disease Mouse Model Are Associated with Increased Degradation of Oxidative Phosphorylation Subunits.非酒精性脂肪性肝病小鼠模型中肝线粒体缺陷与氧化磷酸化亚基降解增加有关。
Mol Cell Proteomics. 2018 Dec;17(12):2371-2386. doi: 10.1074/mcp.RA118.000961. Epub 2018 Aug 31.
9
Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model".儿童和青少年非酒精性脂肪性肝病的发病机制:从“双打击理论”到“多打击模型”。
World J Gastroenterol. 2018 Jul 21;24(27):2974-2983. doi: 10.3748/wjg.v24.i27.2974.
10
Characteristics of hepatic insulin-sensitive nonalcoholic fatty liver disease.肝脏胰岛素敏感型非酒精性脂肪性肝病的特征
Hepatol Commun. 2017 Jul 29;1(7):634-647. doi: 10.1002/hep4.1077. eCollection 2017 Sep.